checked. We can only conclude that it is much more common for normal people to pass acid urine than we had previously appreciated. To further test this contention a random check was made on 54 specimens of urine from patients in a general surgical ward and on which the pH had been measured and recorded on their charts. On only one occasion was the urine specimen found to be alkaline.
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If urinary pH is not as important as previously supposed, then the amount and concentration of uric acid in the urine might be more important. Again our observations showed no significant difference between the 24-hour excretion in the three groups. Though the daily output of uric acid was not changed, however, this was excreted in a significantly smaller volume of more concentrated urine in the patients with ileostomies. This may become important in an acid medium when the solubility of uric acid is greatly reduced. Though this situation may exist in patients with ileostomies it is less important in those with ileorectal anastomoses because of the greater urinary volume.
Examination of the blood samples from each of the three groups did not show any variation from normal among the postoperative patients.
Introduction
The development of inert plastic intrauterine devices (I.U.D.s) which could be manipulated into a linear introducer and inserted in the uterus without anaesthetic has been a significant advance in contraceptive practice. However, their (Tietze and Levit, 1970) . As some of the evidence relating to the mode of action of the I.U.D. suggested that the extent of endometrial coverage was a significant factor, a device, the Dalkon Shield, was designed with this objective as well as minimizing the risk of expulsion, while at the same time its flat shape was intended to reduce the risk of a disturbing level of abnormal bleeding (Davis, 1971) . The initial clinical trials were most encouraging with a pregnancy rate of 1-1% and an expulsion rate of 2-3% and an acceptable bleeding pattern (Davis, 1970) . Since these data were produced by the clinics involved in its development, however, an independent study seemed appropriate.
The Device
The Dalkon Shield is a light, flexible device which conforms to the shape of the average uterine cavity. It consists of a thin, central shield-shaped membrane to increase endometrial contact and has lateral series of small fins, which are designed to promote retention and are thought to permit its accommodation to variations in uterine shape.
The Shield is made of polyvinylacetate and contains barium sulphate for location by x-ray film, together with copper powder and anhydrous cupric sulphate. The addition of copper increases the strength of the plastic. The average standard Shield contains 1-6 mg copper but only a small proportion (0-015 mm2) is exposed on the surface. Dissolution studies indicate that less than 5% of the total copper is released.
INSERTION TECHNIQUE
The Shield device is supplied preloaded on a sterilized inserter which has a notched end (see fig.) . After performing a bimanual examination to check the size and position of the uterus a Cusco speculum is inserted in the vagina. The cervix is cleansed with antiseptic and a single-toothed tenaculum applied to the anterior lip. After sounding the uterus the device on the inserter is passed to the full depth of plane of the uterine cavity. The device is then disengaged in the fundus by turning the inserter through 90' and withdrawing it.
In the normal-sized uterus a knot lies at the level of the exteral os in the cervical appendage; this is present -to aid location.
In 
Discussion
The reintroduction of intrauterine contraceptive devices in the early 1960's was initially followed by widespread enthusiasm and then growing dissatisfaction. The pregnancy and expulsion rates were higher than expected and side effects of pain or bleeding or both necessitated a high pr,oportion of removals. The evidence suggested that a local endometrial action manifesting as a macrophage response, presumably chemotactically induced, prevented conception (Sagiroglu and Sagiroglu, 1970; Sedlis and Reyniak, 1970 ). Davis (1971) then postulated his surface interaction hypothesis that the antifertility effect of an inert I.U.D. bore a direct relation to the surface area of contact between the I.U.D. and the endometrium. Bearing these two points in mind the Dalkon Shield was developed by Davis, a gynaecologist, and Lerner, a bioengineer. Clinical trials conducted by Davis and his associates have been most enthusiastic (Davis, 1971) .
This study, however, has shown a much higher complication rate than that reported by Davis. The pregnancy rate for example is much albove that of 11/100 users at 12 months of use and corresponds more to the 3-8/100 users after one year found in the multicentre U.K. study reported by the Family Planning Research Unit of the University of Exeter (Snowden and Williams, 1973) in which there is no information about the number of women who used a spermicide in addition to the Shield. In the present report about 5 % of participants who asked to use a spermicide did so intermittently.
The expulsion rate of 6 3/100 users in a year is again greater than the 2-3/100 users at 12 months reported by Davis (1971) . This rate, however, is much lower than the expulsion rates ascribed to the more generally used I.U.D.s such as the Lippes Loop C and the Saf-T-Coil of 19 and Lippes Loop D of 12-7/100 users at 12 months' use (Kleinman, 1972) .
The figures for medical removal rates will be greatly influenced by individual doctors' attitudes to this particular problem. Nevertheless our rate corresponds closely to that of 9-7/100 users at one year reported by Ostergard and Broen (1971) and is approaching the removal rates of 11-0/100 users at one year for the Lippes Loop (Tietze and Levit, 1970) . The Exeter survey reported a much lower removal rate for the Shield (4-6/100 users at one year), while the figures of Davis again are the lowest recorded at 2/100 users at one year.
The continuation rate of 69% at our clinic after one year of use again puts the Dalkon Shield on a par with more conventional I.U.D.s (Kleinman, 1972 (Montgomery et al., 1955; Baker and Bywaters, 1957; Polisar, 1959) . So far as we are aware involvement of this joint in ankylosing spondylitis has not been previously reported in the English literature.
Case 1 A man aged 64 with a history of ankylosing spondylitis since 1944 was seen in the rheumatism clinic in 1965. He had been subject to recurrent attacks of iritis, and x-ray pictures of his spine showed severe changes of ankylosing spondylitis. Both hips were involved, and a synovectomy had been performed on the left knee for recurrent effusions. The Rose-Waaler and latex tests were negative.
Since 1956 his voice had become increasingly husky and he had noticed progressive shortness of breath with a constant feeling of obstruction in the throat. Chest x-ray examination showed an old tuberculous focus but no other abnormality. Indirect laryngoscopy showed very little movement of the vocal cords, and on direct laryngoscopy both arytenoid cartilages appeared fixed with no abduction of the cords occurring on inspiration.
In 1966 he became dyspnoeic at rest and developed a pronounced inspiratory and expiratory stridor. A tracheostomy and subsequent left Woodman's operation was performed, and at operation gross
